XML 36 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Cash, Cash Equivalents, Restricted Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]  
Cash Equivalents, Restricted Cash Equivalents and Marketable Securities

3. Cash Equivalents, Restricted Cash Equivalents and Marketable Securities

The following tables summarizes the amortized cost and fair value of the Company's cash equivalents, restricted cash equivalents and marketable securities by major investment category (in thousands):

 

 

 

As of December 31, 2022

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Estimated Fair Value

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

25,313

 

 

$

 

 

$

 

 

$

25,313

 

Total cash equivalents

 

 

25,313

 

 

 

 

 

 

 

 

 

25,313

 

Restricted cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

500

 

 

 

 

 

 

 

 

 

500

 

Total cash equivalents and restricted cash equivalents

 

 

25,813

 

 

 

 

 

 

 

 

 

25,813

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries

 

 

36,563

 

 

 

 

 

 

(107

)

 

 

36,456

 

Commercial paper

 

 

26,631

 

 

 

 

 

 

 

 

 

26,631

 

Corporate debt securities

 

 

6,939

 

 

 

 

 

 

(39

)

 

 

6,900

 

International government

 

 

1,491

 

 

 

 

 

 

(3

)

 

 

1,488

 

Total marketable securities

 

 

71,624

 

 

 

 

 

 

(149

)

 

 

71,475

 

Total cash equivalents, restricted cash equivalents and marketable securities

 

$

97,437

 

 

$

 

 

$

(149

)

 

$

97,288

 

 

 

 

As of December 31, 2021

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Estimated Fair Value

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

115,595

 

 

$

 

 

$

 

 

$

115,595

 

Total cash equivalents

 

$

115,595

 

 

$

 

 

$

 

 

$

115,595

 

As of December 31, 2022, all marketable securities held have maturity dates within one year or less. The Company regularly reviews its available-for-sale marketable securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. As of December 31, 2022, the aggregate difference between the amortized cost and fair value of each security in an unrealized loss position was de minimis. Since any provision for expected credit losses for a security held is limited to the amount the fair value is less than its amortized cost, no allowance for expected credit loss was deemed necessary at December 31, 2022.